Evidence map›Paper›PMID 40301133›Full record

ArticleJournal of neurology2025

Utility of spinal cord axial-T2 sequence in a population-based cohort of multiple sclerosis.

Laura Cacciaguerra, Ajay Madhavan, Elia Sechi, Karl N Krecke, Sean J Pittock, Brian G Weinshenker, W Oliver Tobin, B Mark Keegan, Michel Toledano, Jan-Mendelt Tillema and 6 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Laura CacciaguerraDepartment of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, USA.
Ajay MadhavanDepartment of Radiology, Mayo Clinic, Rochester, USA.
Elia SechiNeurology Unit, University Hospital of Sassari, Sassari, Italy.
Karl N KreckeDepartment of Radiology, Mayo Clinic, Rochester, USA.
Sean J PittockDepartment of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, USA.
Brian G WeinshenkerDepartment of Neurology, University of Virginia, Charlottesville, VA, USA.
W Oliver TobinDepartment of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, USA.
B Mark KeeganDepartment of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, USA.
Michel ToledanoDepartment of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, USA.
Jan-Mendelt TillemaDepartment of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, USA.
Burcu ZeydanDepartment of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, USA.
John J ChenDepartment of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, USA.
Massimo FilippiVita-Salute San Raffaele University, Milan, Italy.
Maria Assunta RoccaVita-Salute San Raffaele University, Milan, Italy.
Orhun H KantarciDepartment of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, USA.
Eoin P FlanaganDepartment of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, USA. Flanagan.Eoin@mayo.edu.ORCID http://orcid.org/0000-0002-6661-2910

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40301133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.